Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Elevated serum preptin concentrations in patients with diabetic nephropathy.

Wang R, Xue A, Zheng W, Wang L, Yan F, Hu W, Lin J, He L.

J Investig Med. 2019 Jun 9. pii: jim-2019-000985. doi: 10.1136/jim-2019-000985. [Epub ahead of print]

PMID:
31182468
2.

Association of Serum Adropin Concentrations with Diabetic Nephropathy.

Hu W, Chen L.

Mediators Inflamm. 2016;2016:6038261. doi: 10.1155/2016/6038261. Epub 2016 Jul 28.

3.

The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.

Lv C, Zhou YH, Wu C, Shao Y, Lu CL, Wang QY.

Diabetes Metab Res Rev. 2015 Oct;31(7):717-24. doi: 10.1002/dmrr.2659. Epub 2015 Jun 25.

PMID:
25952368
4.

Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.

Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH.

Cardiovasc Diabetol. 2016 Jan 7;15:3. doi: 10.1186/s12933-015-0326-9. Erratum in: Cardiovasc Diabetol. 2017 Apr 26;16(1):58.

5.

Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.

Sueud T, Hadi NR, Abdulameer R, Jamil DA, Al-Aubaidy HA.

Diabetes Metab Syndr. 2019 Jan - Feb;13(1):564-568. doi: 10.1016/j.dsx.2018.11.022. Epub 2018 Nov 10.

PMID:
30641767
6.

Association of serum pentraxin 3 concentrations with diabetic nephropathy.

Wang R, Zhang J, Hu W.

J Investig Med. 2016 Aug;64(6):1124-7. doi: 10.1136/jim-2016-000082. Epub 2016 May 27.

PMID:
27233528
7.

[Change and significance of urinary smad3 in type 2 diabetic nephropathy].

Guo KF, Kou JX, Lu JX, Zhang L, Yu HY, Chen HB.

Zhonghua Yi Xue Za Zhi. 2013 Apr 9;93(14):1067-71. Chinese.

PMID:
23902838
8.

RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects.

Nakajima K, Tanaka Y, Nomiyama T, Ogihara T, Ikeda F, Kanno R, Iwashita N, Sakai K, Watada H, Onuma T, Kawamori R.

Diabetes Care. 2003 Mar;26(3):892-8.

PMID:
12610055
9.

[Relationship between serum cystatin-C levels and vibrating perception threshold in patients with 
Type 2 diabetes mellitus].

Yan P, Zhang Z, Xu Y, Wan Q, Ma H, He J.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016 Jan;41(1):58-64. doi: 10.11817/j.issn.1672-7347.2016.01.009. Chinese.

10.

Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients.

Chang YH, Lin KD, Wang CL, Hsieh MC, Hsiao PJ, Shin SJ.

Diabetes Metab Res Rev. 2008 Nov-Dec;24(8):629-34. doi: 10.1002/dmrr.894.

PMID:
18973209
11.

Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.

Yang G, Li L, Chen W, Liu H, Boden G, Li K.

Ann Med. 2009;41(1):52-6. doi: 10.1080/07853890802244142.

PMID:
18618352
12.

Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.

Bouvet BR, Paparella CV, Arriaga SM, Monje AL, Amarilla AM, Almará AM.

Arq Bras Endocrinol Metabol. 2014 Nov;58(8):798-801. Epub 2014 Nov 1.

PMID:
25465599
13.

Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy.

Mahfouz MH, Assiri AM, Mukhtar MH.

Biomark Insights. 2016 Feb 16;11:31-40. doi: 10.4137/BMI.S33191. eCollection 2016.

14.

ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.

Zhang P, Gao J, Pu C, Feng G, Wang L, Huang L, Zhang Y.

Clin Chim Acta. 2017 Mar;466:31-37. doi: 10.1016/j.cca.2017.01.006. Epub 2017 Jan 7.

PMID:
28073663
15.

Assessment of human cartilage glycoprotein 39 (YKL-40), preptin, and nitric oxide in adolescent patients with type 1 diabetes and its relation to cardiorenal affection.

Abd El Dayem SM, Battah AA, El Shehaby A, Abd Allah N.

J Pediatr Endocrinol Metab. 2015 Mar;28(3-4):309-14. doi: 10.1515/jpem-2014-0359.

PMID:
25719300
16.

The Kidney Specific Protein myo-Inositol Oxygenase, a Potential Biomarker for Diabetic Nephropathy.

Gao P, Xu B, Song P, Zhu X, Yuan S, Kanwar YS, Sun L.

Kidney Blood Press Res. 2018;43(6):1772-1785. doi: 10.1159/000495635. Epub 2018 Nov 30.

17.

Galectin-3 as a prognostic biomarker for diabetic nephropathy.

Hodeib H, Hagras MM, Abdelhai D, Watany MM, Selim A, Tawfik MA, Elsebaey MA, Elshweikh SA.

Diabetes Metab Syndr Obes. 2019 Mar 13;12:325-331. doi: 10.2147/DMSO.S194410. eCollection 2019.

18.

Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy.

Ma X, An L, Wang Q.

Endocr Metab Immune Disord Drug Targets. 2017;17(2):114-124. doi: 10.2174/1871530317666170711164347.

PMID:
28699485
19.

Evaluation of serum Spondin 2 levels in the different stages of Type 2 diabetic nephropathy.

Kahvecioglu S, Guclu M, Ustundag Y, Gul CB, Dogan I, Dagel T, Esen B, Akturk Esen S, Celik H, Esen I.

Nephrology (Carlton). 2015 Oct;20(10):721-726. doi: 10.1111/nep.12507.

PMID:
25973958
20.

Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.

Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.

J Diabetes Complications. 2008 Nov-Dec;22(6):384-8. doi: 10.1016/j.jdiacomp.2007.07.004. Epub 2008 Apr 16.

PMID:
18413152

Supplemental Content

Support Center